Yamaguchi Hiroaki | Department Of Cardiology Tokyo Metropolitan Hiroo General Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PE-273 Effects of Corticosteroid Therapy on Cardiac Sarcoidosis with Ventricular Tachycardia(Cardiomyopathy, Clinical 2 (M) : PE47)(Poster Session (English))
PE-027 Effects of Pacing Modes on Detection and Parameters of Late Potential in Signal Averaged Electrogram(Arrhythmia, diagnosis/pathophysiology/EPS-06, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-010 Increased Incidences of Coronary Vasospasm by Acetylcholine Injection in Patients with Metabolic Syndrome(Angina pectoris, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
OJ-035 A Combined Approach to Catheter Ablation of Paroxysmal and Persistent Atrial Fibrillation(Arrhythmia, therapy-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Effects of Bepridil and Amiodarone for Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation Compared to Na Channel Blockers
Significance of Plasma Brain Natriuretic Peptide in Patients with Reversible Left Ventricular Dysfunction takotsubo Cardiomyopathy
Effects of Quinidine and Aminophyline for Prevention of Ventricular Fibrillation (VF) Induction in Patients with Brugada Syndrome
Clinical Evaluation of Takotsubo Cardiomyopathy, a Reversible Form of Left Ventricular Dysfunction, with ^I-MIBG Myocardial Scintigraphy
Effects of Sodium Channel Blockers and Bepridil for Maintenance of Sinus Rhythm after Electrical Cardioversion of Recurrent Atrial Fibrillation
Usefulness of Programmed Ventricular Stimulation In Postinfarction Patients without Spontaneous Sustained Ventricular Tachyarrhythmias
Significance of abnormally low value of RMS40 in SAECG as a predictor of sustained VT in patients with OMI
Electrophysiological Spectrum Of Asymptomatic Patients With Typical ECG Changes Compatible With Brugada Syndrome
PE-226 Cardiac Autonomic Nervous Function in Patients with Takotsubo Cardiomyopathy(ECG/Body Surface Potential Mapping/Holter 4 (A) : PE39)(Poster Session (English))
PE-545 Radiofrequency Catheter Ablation (RFCA) Using the Electroanatomical Mapping System (CARTO) for Ventricular Tachycardia (VT) in Ischemic and Non-ischemic Origins(Arrhythmia, therapy-13 (A) PE92,Poster Session (English),The 70th Anniversary Annual Sc
Efficacy of Rhythm Control for Persistent/Paroxysmal Atrial Fibrillation by Antiarhythmic Drugs with ACE Inhibitors or Angiotensin II Receptor Blockers (Arrhythmia, Pharmacological Therapy 6 (A), The 69th Annual Scientific Meeting of the Japanese Circulat
Usefulness of Late Potential from Signal-averaged Electrocardiogram for Risk Stratification in the Brugada Syndrome(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
OJ-452 Preventive effect for recurrence of atrial fibrillation by Bepridil in patients with low left atrial appendage function.(Arrhythmia, Pharmacological Therapy 5 (A) : OJ55)(Oral Presentation (Japanese))
OJ-428 Reevaluation of Late Potential as a New Predictor of Life Threatening Cardiac Arrhythmias in the era of percutaneous cardiac intervention(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese))
OJ-231 Effects of Isoproterenl and Anti-arrhythmic Drugs for Prevention of Atrial Fibrillation Induction in Patients with Brugada Syndrome(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese))

もっと見る

スポンサーリンク